Network meta-analysis of the efficacy and safety of antidepressants for acutely ill elderly patients with major depressive disorder

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2018.11.632 ◽

2019 ◽

Vol 29 ◽

pp. S417

Author(s):

M. Krause ◽

S. Leucht

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Meta Analysis ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

Network meta-analysis of the efficacy and safety of antidepressants for acutely ill elderly patients with major depressive disorder

10.26226/morressier.5b681763b56e9b005965c07d ◽

2018 ◽

Author(s):

Marc Krause ◽

Stefan Leucht

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Meta Analysis ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies

The International Journal of Neuropsychopharmacology ◽

10.1093/ijnp/pyw043.152 ◽

2016 ◽

Vol 19 (Suppl_1) ◽

pp. 55-55

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Meta Analysis ◽

Adjunctive Treatment ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

Efficacy and Safety of Vortioxetine and Duloxetine 60 mg Compared Placebo for the Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis

Journal of Behavioral and Brain Science ◽

10.4236/jbbs.2015.510041 ◽

2015 ◽

Vol 05 (10) ◽

pp. 430-439

Author(s):

Masoud Behzadifar ◽

Abouzar Keshavarzi ◽

Abed Tofighian ◽

Mohammad Rastian ◽

Mohammad Zobidi ◽

...

Keyword(s):

Systematic Review ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Meta Analysis ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis

Psychopharmacology ◽

10.1007/s00213-014-3633-z ◽

2014 ◽

Vol 232 (1) ◽

pp. 7-16 ◽

Author(s):

Jie Fu ◽

Yangmei Chen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Meta Analysis ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

The efficacy and safety of 10 mg/day vortioxetine compared to placebo for adult major depressive disorder: a meta-analysis

African Health Sciences ◽

10.4314/ahs.v19i1.48 ◽

2019 ◽

Vol 19 (1) ◽

pp. 1716

Author(s):

Jiahuan Zheng ◽

Zhaoyu Wang ◽

Enli Li

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Meta Analysis ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s103173 ◽

2016 ◽

pp. 523

Author(s):

Dihui Ma ◽

Guangjian Li ◽

Xu Wang

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Major Depressive ◽

Randomized Controlled

Download Full-text

P.2.c.006 Efficacy and safety of bupropion extended release in elderly patients with major depressive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(06)70340-6 ◽

2006 ◽

Vol 16 ◽

pp. S315-S316 ◽

Author(s):

W. Chrzanowski ◽

R. Rousseau ◽

K. Hewett ◽

M.D. Gee ◽

D. Wightman ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Efficacy And Safety ◽

Major Depressive

Download Full-text

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0b013e3283542457 ◽

2012 ◽

Vol 27 (4) ◽

pp. 215-223 ◽

Author(s):

Cornelius Katona ◽

Thomas Hansen ◽

Christina Kurre Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Efficacy and safety of agomelatine oral administration (25 to 50 mg/day) in elderly patients suffering from major depressive disorder: an 8-week, randomised, double-blind, flexible-dose, parallel groups, placebo-controlled, international, multicentre study followed by an extension double-blind treatment period of 16 weeks

http://isrctn.org/> ◽

10.1186/isrctn57507360 ◽

2013 ◽

Author(s):

Reinhard Heun

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Oral Administration ◽

Multicentre Study ◽

Treatment Period ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Download Full-text

Evaluation Efficacy and Safety of Vortioxetine 20 mg/d versus Placebo for Treatment Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Pharmacology &amp Pharmacy ◽

10.4236/pp.2015.64024 ◽

2015 ◽

Vol 06 (04) ◽

pp. 221-231 ◽

Author(s):

Masoud Behzadifar ◽

Hamidreza Dehghan ◽

Korush Saki ◽

Meysam Behzadifar ◽

Abouzar Keshavarzi ◽

...

Keyword(s):

Systematic Review ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Major Depressive ◽

Randomized Controlled

Download Full-text